Overview
The First Affiliated Hospital of Guangzhou Medical University is one of the leading medical institutions in China, even globally, for the diagnosis and treatment of complex respiratory diseases. As a core team of the National Respiratory Medicine Center and the State Key Laboratory of Respiratory Diseases, its interventional respiratory team, led by Professor Li Shiyue, utilizes proven and cutting-edge interventional technologies to successfully treat patients with intractable respiratory conditions. We are among the few medical facilities in China that offer a full spectrum of interventional respiratory solutions, including precision diagnosis of pulmonary nodules, minimally invasive treatment of central lung cancer, complex airway stenosis management, and interventional hemostasis for massive hemoptysis.
Patients with extremely challenging respiratory conditions turn to our interventional respiratory team because of its unparalleled expertise in all types of respiratory diseases, especially complex airway lesions, peripheral pulmonary nodules, refractory hemoptysis, and minimally invasive interventional treatment of lung tumors. Backed by the hospital's strong academic and research platform, the team has also made important breakthroughs in the research and clinical transformation of interventional technologies, providing strong support for improving the prognosis of patients with severe respiratory diseases.
